Terms: = Prostate cancer AND CDK6, MGC59692, 1021, Q00534, ENSG00000105810, PLSTIRE AND Staging
4 results:
1. Radioisotope-guided Lymphadenectomy for Pelvic Lymph Node staging in Patients With Intermediate- and High-risk prostate cancer (The Prospective SENTINELLE Study).
Lannes F; Baboudjian M; Ruffion A; Rouy M; Giammarile F; Rousseau T; Kraeber-Bodéré F; Rousseau C; Rusu D; Colombié M; Brenot-Rossi I; Rossi D; Mottet N; Bastide C
J Urol; 2023 Feb; 209(2):364-373. PubMed ID: 36331157
[TBL] [Abstract] [Full Text] [Related]
2.
Moradi F; Duan H; Song H; Davidzon GA; Chung BI; Thong AEC; Loening AM; Ghanouni P; Sonn G; Iagaru A
J Nucl Med; 2022 Dec; 63(12):1822-1828. PubMed ID: 35512996
[TBL] [Abstract] [Full Text] [Related]
3. Importance of non-regional lymph nodes in assigning risk in primary metastatic prostate cancer.
Ali A; Hoyle A; Mistry H; Clarke NW
BJU Int; 2019 Jan; 123(1):65-73. PubMed ID: 29777564
[TBL] [Abstract] [Full Text] [Related]
4. Expression and Role of PAICS, a De Novo Purine Biosynthetic Gene in prostate cancer.
Chakravarthi BV; Goswami MT; Pathi SS; Dodson M; Chandrashekar DS; Agarwal S; Nepal S; Hodigere Balasubramanya SA; Siddiqui J; Lonigro RJ; Chinnaiyan AM; Kunju LP; Palanisamy N; Varambally S
Prostate; 2017 Jan; 77(1):10-21. PubMed ID: 27550065
[TBL] [Abstract] [Full Text] [Related]
